Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

The role of nitric oxide in pleural disease.

Authors:
Ourania S Kotsiou Konstantinos I Gourgoulianis Sotirios G Zarogiannis

Respir Med 2021 Apr 23;179:106350. Epub 2021 Feb 23.

Department of Physiology, Faculty of Medicine, University of Thessaly, BIOPOLIS, 41500, Larissa, Greece.

Nitric oxide (NO) regulates various physiological and pathophysiological functions in the lungs. However, there is much less information about the effects of NO in the pleura. The present review aimed to explore the available evidence regarding the role of NO in pleural disease. NO, has a double-edged role in the pleural cavity. It is an essential signaling molecule mediating various physiological cell functions such as lymphatic drainage of the serous cavities, the immune response to intracellular multiplication of pathogens, and downregulation of neutrophil migration, but also induces genocytotoxic and mutagenic effects when present in excess. NO is implicated in the pathogenesis of asbestos-related or exudative pleural disease and mesothelioma. From a clinical point of view, the fraction of exhaled NO has been suggested as a potential non-invasive tool for the diagnosis of benign asbestos-related disorders. Under experimental conditions, NO-mimetics were found to attenuate hypoxia-induced therapy resistance in mesothelioma. Similarly, hybrid agents consisting of an NO donor coupled with a parent anti-inflammatory drug showed an enhancement of the anti-inflammatory activity of anti-inflammatory drugs. However, given the paucity of research work performed over the last years in this area, further research should be undertaken to establish reliable conclusions with respect to the feasibility of determining or targeting the NO signaling pathway for pleural disease diagnosis and therapeutic management.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2021.106350DOI Listing
April 2021

Publication Analysis

Top Keywords

pleural disease
16
role pleural
8
nitric oxide
8
pleural
5
benign asbestos-related
4
diagnosis benign
4
tool diagnosis
4
non-invasive tool
4
potential non-invasive
4
exhaled suggested
4
suggested potential
4
asbestos-related disorders
4
conditions no-mimetics
4
hypoxia-induced therapy
4
therapy resistance
4
attenuate hypoxia-induced
4
no-mimetics attenuate
4
experimental conditions
4
fraction exhaled
4
disorders experimental
4

Keyword Occurance

Similar Publications

Non-immune hydrops fetalis secondary to congenital chylothorax with diffuse interstitial lung disease: a diagnostic conundrum.

Authors:
Alvin Jia Hao Ngeow Mei Yoke Chan Oon Hoe Teoh Sarat Kumar Sanamandra Daisy Kwai Lin Chan

BMJ Case Rep 2021 Apr 16;14(4). Epub 2021 Apr 16.

Department of Neonatal and Developmental Medicine, Singapore General Hospital, Singapore.

A Chinese male infant was born at 35 weeks weighing 2935 g to a mother with polyhydramnios and prenatal hydrops fetalis. He developed marked respiratory distress secondary to bilateral congenital chylothorax and required pleural drainage, high frequency oscillation and inhaled nitric oxide therapy. He was extubated to non-invasive ventilation by day 14. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Endometriosis-Related Pleural Effusion: A Case Report and a PRISMA-Compliant Systematic Review.

Authors:
Ping Wang Zhilan Meng Yakun Li Zuojun Xu

Front Med (Lausanne) 2021 30;8:631048. Epub 2021 Mar 30.

Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China.

Endometriosis-related pleural effusion (PE) is a relatively rare but treatable cause of bloody PE. The clinical characteristics and outcome of patients with endometriosis-related PE remain unknown. We present a case of endometriosis-related PE diagnosed on pleural fluid cytology. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Malignant pleural mesothelioma co-opts BCL-X and autophagy to escape apoptosis.

Authors:
Duo Xu Shun-Qing Liang Zhang Yang Haitang Yang Rémy Bruggmann Simone Oberhaensli Sabina Berezowska Thomas M Marti Sean R R Hall Patrick Dorn Gregor J Kocher Ralph A Schmid Ren-Wang Peng

Cell Death Dis 2021 Apr 15;12(4):406. Epub 2021 Apr 15.

Division of General Thoracic Surgery, Inselspital, Bern University Hospital, Bern, Switzerland.

Escape from programmed cell death is a hallmark of cancer. In this study, we investigated the anti-apoptotic mechanisms and explored the therapeutic potential of BCL-2 homology domain-3 (BH3) mimetics in malignant pleural mesothelioma (MPM), a lethal thoracic malignancy with an extreme dearth of treatment options. By implementing integrated analysis of functional genomic data of MPM cells and quantitative proteomics of patients' tumors, we identified BCL-X as an anti-apoptotic driver that is overexpressed and confers an oncogenic dependency in MPM. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Debulking surgery for functional pleural dissemination of parathyroid carcinoma-case report.

Authors:
Sachi Kawagishi Soichiro Funaki Naoko Ose Kenji Kimura Kosuke Mukai Michio Otsuki Yasushi Shintani

J Cardiothorac Surg 2021 Apr 15;16(1):86. Epub 2021 Apr 15.

Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, 2-2-L5, Yamadaoka, Suita, 565-0871, Osaka, Japan.

Background: A rare cause of primary hyperparathyroidism (PHPT) is a parathyroid carcinoma. Hypercalcemia with an elevated parathyroid hormone (PTH) level seen in recurrent and metastasis disease cases is often refractory to medical therapy, thus surgical resection is recommended when possible. We performed debulking surgery for pleural dissemination of parathyroid cancer for improvement of symptoms in a patient with hypercalcemia. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Localized pleural metastasis without other organ metastases after nephrectomy for renal cell carcinoma.

Authors:
Zenya Saito Kenichi Hata Saiko Nishioka Kentaro Tamura Nobumasa Tamura Masahiro Yoshida Kentaro Kasa Jun Hirano Masataka Masubuchi Kazuyoshi Kuwano

Respir Med Case Rep 2021 19;33:101388. Epub 2021 Mar 19.

Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.

We present a case of a 69-year-old man who had localized pleural metastasis without other organ metastases after nephrectomy for right renal cell carcinoma (RCC). He complained of respiratory symptoms for more than two years after the operation and was confirmed to have right pleural effusion and multiple pleural masses on computed tomography (CT). There were no abnormal findings in the other organs, but the pleural mass gradually increased in size on CT. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap